W. MARK WATSON, CPA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

abrdn Healthcare Investors

Filing Date Source Excerpt
2022-04-12 W. Mark Watson, CPA: Mr. Watson was appointed as a Trustee effective June 9, 2022. No compensation data was provided for Mr. Watson.
2023-04-11 Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing. He is a member of the Board of Directors of Vaxart Inc., Global Health MCS and the Moffitt Cancer Center. The members of each Fund's Audit Committee are Mr. Kent, Ms. Goetz and Mr. Watson. Mr. Kent is the Chairman of each Fund's Audit Committee. The members of each Fund's Valuation Committee are Mr. Bailey, Ms. Goetz, Dr. Omstead and Mr. Watson. Mr. Bailey is the Chairman of each Fund's Valuation Committee. For the fiscal year ended September 30, 2022, the Independent Trustees as a group received $2,098 from HQH, $2,037 from THQ and $1,140 from THW for reimbursed expenses. The following table sets forth information regarding compensation of the Trustees and Executive Officer by each Fund for the fiscal year ended September 30, 2022... W. Mark Watson, CPA $44,333 total compensation.

abrdn Life Sciences Investors

Filing Date Source Excerpt
2022-04-12 Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing... He received his undergraduate degree in Accounting from Marquette University.
2023-04-11 Mr. Watson is a Certified Public Accountant with over 40 years of experience in public accounting and auditing, having spent his entire career from January 1973 to June 2013 at Deloitte Touche Tohmatsu.

Data sourced from SEC filings. Last updated: 2025-10-12